---
document_datetime: 2025-01-31 09:15:14
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/abiraterone-krka-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: abiraterone-krka-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.9185983
conversion_datetime: 2025-12-20 08:26:05.864526
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Abiraterone Krka

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                 | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0007               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                      | 28/01/2025                          |                                             | PL                               |           |
| IA/0006              | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites | 03/12/2024                          | n/a                                         |                                  |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |            |                        |              |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------|
| IB/0005/G | This was an application for a group of variations. B.I.a.3.z - Change in batch size (including batch size ranges) of AS or intermediate - Other variation B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or | 18/09/2024 | n/a        |                        | manufacturer |
| II/0004   | B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 15/02/2024 | n/a        |                        |              |
| IB/0003   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 23/11/2022 | 16/12/2022 | SmPC, Labelling and PL |              |

<div style=\"page-break-after: always\"></div>

|         | the MAH                                                                                                                 |            |            |      |
|---------|-------------------------------------------------------------------------------------------------------------------------|------------|------------|------|
| IB/0002 | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation | 05/07/2022 | 16/12/2022 | SmPC |